The epidemiology of mild cognitive impairment (MCI) and Alzheimer's disease (AD) in community-living seniors: Protocol of the MemoVie cohort study, Luxembourg

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Perquin, Magali ^a   Schuller, Anne Marie ^b,c   Vaillant, Michel ^a   Diederich, Nico ^d   Bisdorff, Alexandre ^e   Leners, Jean Claude ^f   D'Incau, Marylène ^a   Ludewig, Jean Luc ^a   Hoffmann, Danielle ^b   Ulbricht, Dirk ^e   Thoma, Stephanie ^f   Dondelinger, René ^e   Heuschling, Paul ^b   Couffignal, Sophie ^a   Dartigues, Jean François ^g   Lair, Marie Lise ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^c Rehazenter ^*  (Luxembourg)

^d CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^e Centre Hospitalier Emile Mayrisch CHEM   (Luxembourg)

^f Pontalize Erpeldange and Ettelbruck ^*  (Luxembourg)

^g INSERM   (France)

Author keywords

Aging; Alzheimers disease; Cognition; Epidemiology; Mild cognitive impairment; Nested case control cohort; Population based study

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; HUMAN; INDEPENDENT LIVING; LUXEMBOURG; METHODOLOGY; MILD COGNITIVE IMPAIRMENT; PREVALENCE; RISK FACTOR;

AGED; ALZHEIMER DISEASE; COHORT STUDIES; HUMANS; INDEPENDENT LIVING; LUXEMBOURG; MILD COGNITIVE IMPAIRMENT; PREVALENCE; RESEARCH DESIGN; RISK FACTORS;

EID: 84863670197     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-519     Document Type: Article

References (52)

1. Global prevalence of dementia: a Delphi consensus study. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, et al. Lancet 2005 366 9503 2112 2117 16360788 (Pubitemid 41797645)
2. Mild cognitive impairment: clinical characterization and outcome. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E, Arch Neurol 1999 56 3 303 308 10.1001/archneur.56.3.303 10190820 (Pubitemid 29120227)
3. Mild cognitive impairment as a diagnostic entity. Petersen RC, J Intern Med 2004 256 3 183 194 10.1111/j.1365-2796.2004.01388.x 15324362 (Pubitemid 39222988)
4. Prevalence of mild cognitive impairment and its subtypes in the Heinz Nixdorf Recall study cohort. Dlugaj M, Weimar C, Wege N, Verde PE, Gerwig M, Dragano N, Moebus S, Jockel KH, Erbel R, Siegrist J, Dement Geriatr Cogn Disord 2010 30 4 362 373 10.1159/000320988 20956854
5. Is it time to separate subjective cognitive complaints from the diagnosis of mild cognitive impairment? Mitchell AJ, Age Ageing 2008 37 5 497 499 10.1093/ageing/afn147 18682432
6. Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Unverzagt FW, Gao S, Baiyewu O, Ogunniyi AO, Gureje O, Perkins A, Emsley CL, Dickens J, Evans R, Musick B, et al. Neurology 2001 57 9 1655 1662 10.1212/WNL.57.9.1655 11706107 (Pubitemid 33055485)
7. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, et al. Arch Neurol 2003 60 10 1385 1389 10.1001/archneur.60.10.1385 14568808 (Pubitemid 37248799)
8. The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, Ivnik RJ, Tangalos EG, Petersen RC, Rocca WA, Neuroepidemiology 2008 30 1 58 69 10.1159/000115751 18259084 (Pubitemid 351311727)
9. Age-specific and Sex-specific Prevalence and Incidence of Mild Cognitive Impairment, Dementia, and Alzheimer Dementia in Blacks and Whites: A Report From the Einstein Aging Study. Katz MJ, Lipton RB, Hall CB, Zimmerman ME, Sanders AE, Verghese J, Dickson DW, Derby CA, Alzheimer Dis Assoc Disord 2011
10. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias. Allan LM, Ballard CG, Burn DJ, Kenny RA, J Am Geriatr Soc 2005 53 10 1681 1687 10.1111/j.1532-5415.2005.53552.x 16181166 (Pubitemid 43109930)
11. Just noticeable difference in olfaction: a discriminative tool between healthy elderly and patients with cognitive disorders associated with dementia. Hidalgo J, Chopard G, Galmiche J, Jacquot L, Brand G, Rhinology 2011 49 5 513 518 22125780
12. Luk G, The anatomy of the bilingual influence of cognition: Levels of functional use and proficiency of language Unpublished doctoral dissertation, York University, Canada 2008
13. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease. Berres M, Monsch AU, Bernasconi F, Thalmann B, Stahelin HB, Stud Health Technol Inform 2000 77 195 199 11187541
14. Kaplan EF GH, Weintraub S, The Boston Naming Test Lea & Febiger, Philadelphia: PA 1983
15. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Folstein MF, Folstein SE, McHugh PR, J Psychiatr Res 1975 12 3 189 198 10.1016/0022-3956(75)90026-6 1202204
16. Preclinical prediction of AD using neuropsychological tests. Albert MS, Moss MB, Tanzi R, Jones K, J Int Neuropsychol Soc 2001 7 5 631 639 10.1017/S1355617701755105 11459114 (Pubitemid 32700957)
17. Dalla Barba G, Boller F: [Neuropsychological aspects of Alzheimer's disease]. Traykov L, Marcie P, Rev Neurol (Paris) 1999 155 Suppl 4 38 43
18. Neuropsychological impairment in the early Alzheimer's disease. Traykov L, Rigaud AS, Cesaro P, Boller F, Encephale 2007 33 3 Pt 1 310 316 17675928 (Pubitemid 47220327)
19. American Psychiatric Association, Diagnostic and statistical manual of mental disorders American Psychiatric Association, Washington DC 4 1994
20. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Arnaiz E, Almkvist O, Acta Neurol Scand Suppl 2003 179 34 41 12603249
21. Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery. Barth S, Schonknecht P, Pantel J, Schroder J, Fortschr Neurol Psychiatr 2005 73 10 568 576 10.1055/s-2004-830249 16217697 (Pubitemid 41539071)
22. Charakterisierung kognitiver Einbuen von Patienten mit Mild Cognitive Impairment(MCI) in der CERADScreeningbatterie. Schreiber YA, Ackl N, Sonntag A, Zihl J, Zeitschrift für Neuropsychologie 2005 16 3 139 149 10.1024/1016-264X.16.3.139 19349661
23. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis. Diehl J, Monsch AU, Aebi C, Wagenpfeil S, Krapp S, Grimmer T, Seeley W, Forstl H, Kurz A, J Geriatr Psychiatry Neurol 2005 18 1 39 44 10.1177/0891988704272309 15681627 (Pubitemid 40313190)
24. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years. Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC, Tariot PN, Silverman JM, Clark CM, Welsh-Bohmer KA, et al. Alzheimers Dement 2008 4 2 96 109 10.1016/j.jalz.2007.08.005 18631955 (Pubitemid 351373200)
25. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C, Neurology 1989 39 9 1159 1165 10.1212/WNL.39.9.1159 2771064 (Pubitemid 19239715)
26. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease. Gillen TE, Gregg KM, Yuan H, Kurth MC, Krishnan KR, Psychopharmacol Bull 2001 35 2 83 96 12397889
27. et les membres du GREMEM: Lépreuve de rappel libre/rappel indicé 16 items (RL/RI-16). Van der Linden M, Coyette F, Poitrenaud J, Lévaluation des troubles de la mémoire Présentation de quatre tests de mémoire épisodique (avec leur étalonnage) et les membres du GREMEM, Marseille: Solal, Linden M, Adam S, Agniel A, 2004 22934319
28. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, et al. Lancet Neurol 2007 6 8 734 746 10.1016/S1474-4422(07)70178-3 17616482 (Pubitemid 47058377)
29. The FAB: a Frontal Assessment Battery at bedside. Dubois B, Slachevsky A, Litvan I, Pillon B, Neurology 2000 55 11 1621 1626 10.1212/WNL.55.11.1621 11113214
30. Frontal assessment battery and differential diagnosis of frontotemporal dementia and Alzheimer disease. Slachevsky A, Villalpando JM, Sarazin M, Hahn-Barma V, Pillon B, Dubois B, Arch Neurol 2004 61 7 1104 1107 10.1001/archneur.61.7.1104 15262742 (Pubitemid 38915953)
31. A short neuropsychologic and cognitive evaluation of frontotemporal dementia. Valverde AH, Jimenez-Escrig A, Gobernado J, Baron M, Clin Neurol Neurosurg 2009 111 3 251 255 10.1016/j.clineuro.2008.10.012 19062159
32. Brickenkamp R, Aufmerksamkeits-Belastungs-Test. 9., überarbeitete und neu normierte Auflage Hogrefe Verlag, Göttingen 2002
33. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Amieva H, Letenneur L, Dartigues JF, Rouch-Leroyer I, Sourgen C, D'Alchee-Biree F, Dib M, Barberger-Gateau P, Orgogozo JM, Fabrigoule C, Dement Geriatr Cogn Disord 2004 18 1 87 93 10.1159/000077815 15087583 (Pubitemid 38822744)
34. The Cognitive Difficulties Scale. McNair D, Kahn R, Crook SF T, Bartus R, Assessment in Geriatric Psychopharmacology Mark Powley and Associates, New Canaan, CT 1983 137 143
35. Thomas-Anterion C, Ribas C, Honoré-Masson S, Berne G, Ruel JH, Laurent B: Le questionnaire de plainte cognitive (QPC): Un outil de recherche de plainte suspecte d'évoquer une maladie d'Alzheimer? Serdi, Paris, FRANCE 2003
36. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Jorm AF, Psychol Med 1994 24 1 145 153 10.1017/S003329170002691X 8208879 (Pubitemid 24083690)
37. Complaints of cognitive decline in the elderly: a comparison of reports by subjects and informants in a community survey. Jorm AF, Christensen H, Henderson AS, Korten AE, Mackinnon AJ, Scott R, Psychol Med 1994 24 2 365 374 10.1017/S0033291700027343 8084932 (Pubitemid 24158850)
38. An inventory for measuring clinical anxiety: psychometric properties. Beck AT, Epstein N, Brown G, Steer RA, J Consult Clin Psychol 1988 56 6 893 897 3204199 (Pubitemid 19008360)
39. Computerized tests of attention, memory and motor performance applied to geriatric research. Yesavage JA, Tinklenberg JR, Presse Med 1983 12 48 3170 3172 6228935 (Pubitemid 14217651)
40. Studies of Illness in the Aged. The Index of Adl: A Standardized Measure of Biological and Psychosocial Function. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW, JAMA 1963 185 914 919 10.1001/jama.1963.03060120024016 14044222
41. Assessment of older people: self-maintaining and instrumental activities of daily living. Lawton MP, Brody EM, Gerontologist 1969 9 3 179 186 10.1093/geront/9.3-Part-1.179 5349366
42. Circumferences. In Anthropometric Standardization Reference Manual Abridged Edition. Callaway CW, Chumlea WC, Bouchard C, Himes JH, Lohman TG, Martin AD, Mitchell CD, Mueller WH, Roche AF, Seefeldt VD, Human Kinetics, Lohman TG, Roche AF, Martorell R, 1991 39 54
43. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Doty RL, Shaman P, Dann M, Physiol Behav 1984 32 3 489 502 10.1016/0031-9384(84)90269-5 6463130 (Pubitemid 14148126)
44. Olfactory screening test in mild cognitive impairment. Eibenstein A, Fioretti AB, Simaskou MN, Sucapane P, Mearelli S, Mina C, Amabile G, Fusetti M, Neurol Sci 2005 26 3 156 160 10.1007/s10072-005-0453-2 16086128 (Pubitemid 41194598)
45. members of the UPDRS Development Committee: The Unified Parkinsons Disease Rating Scale. Fahn S, Elton R, Recent developments in Parkinsons disease MacMillan HealthCare Information, Florham Park, NJ, Fahn SMC, Calne D, Goldstein M, 1987 153 163 22704258
46. Parkinsonian signs in subjects with mild cognitive impairment. Boyle PA, Wilson RS, Aggarwal NT, Arvanitakis Z, Kelly J, Bienias JL, Bennett DA, Neurology 2005 65 12 1901 1906 10.1212/01.wnl.0000188878.81385.73 16380610 (Pubitemid 43970107)
47. Prevalence of parkinsonian signs and associated mortality in a community population of older people. Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, Evans DA, N Engl J Med 1996 334 2 71 76 10.1056/ NEJM199601113340202 8531961 (Pubitemid 26017932)
48. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. Podsiadlo D, Richardson S, J Am Geriatr Soc 1991 39 2 142 148 1991946
49. Risk factors for falls among elderly persons living in the community. Tinetti ME, Speechley M, Ginter SF, N Engl J Med 1988 319 26 1701 1707 10.1056/NEJM198812293192604 3205267 (Pubitemid 19019577)
50. Clinical practice. Preventing falls in elderly persons. Tinetti ME, N Engl J Med 2003 348 1 42 49 10.1056/NEJMcp020719 12510042 (Pubitemid 36026346)
51. A longitudinal study of gait and balance dysfunction in normal older people. Baloh RW, Ying SH, Jacobson KM, Arch Neurol 2003 60 6 835 839 10.1001/archneur.60.6.835 12810488 (Pubitemid 36705971)
52. Validity of the multi-directional reach test: a practical measure for limits of stability in older adults. Newton RA, J Gerontol A Biol Sci Med Sci 2001 56 4 248 252 10.1093/gerona/56.4.M248 11283199